Bariatric surgery in a patient with complete MC4R deficiency

International Journal of Obesity

Volumn 35, Issue 3, 2011, Pages 457-461

  Aslan, I R ^a   Ranadive, S A ^b   Ersoy, B A ^a   Rogers, S J ^a   Lustig, R H ^a   Vaisse, C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

adolescent; bariatric surgery; gastric banding; melanocortin 4 receptor; vagotomy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GHRELIN; GLUCOSE; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MELANOCORTIN 4 RECEPTOR; TRIACYLGLYCEROL;

ADENOIDECTOMY; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BARIATRIC SURGERY; BIRTH WEIGHT; BODY MASS; CALORIC INTAKE; CASE REPORT; CELL STRAIN HEK293; CHOLESTEROL BLOOD LEVEL; GASTRIC BANDING; GASTROESOPHAGEAL REFLUX; GLUCOSE BLOOD LEVEL; HETEROZYGOSITY LOSS; HUMAN; HYPERPHAGIA; LAPAROSCOPIC SURGERY; MALE; MELANOCORTIN 4 RECEPTOR DEFICIENCY; METABOLIC DISORDER; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; TONSILLECTOMY; TRIACYLGLYCEROL BLOOD LEVEL; TRUNCUS VAGOTOMY; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; BARIATRIC SURGERY; HUMANS; MALE; OBESITY, MORBID; RECEPTOR, MELANOCORTIN, TYPE 4; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 79952709079     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.168     Document Type: Article

References (25)

1. O'Brien PE, Sawyer SM, Laurie C, Brown WA, Skinner S, Veit F et al. Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA 2010; 303: 519-526.
2. Ranadive SA, Vaisse C. Lessons from extreme human obesity: monogenic disorders. Endocrinol Metab Clin North Am 2008; 37: 733-751, x.
3. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuro-endocrine and autonomic control circuits in the brain. Mol Endocrinol 1994; 8: 1298-1308. (Pubitemid 24335073)
4. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-671. (Pubitemid 30205071)
5. Lubrano-Berthelier C, Dubern B, Lacorte JM, Picard F, Shapiro A, Zhang S et al. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J Clin Endocrinol Metab 2006; 91: 1811-1818.
6. Calton MA, Ersoy BA, Zhang S, Kane JP, Malloy MJ, Pullinger CR et al. Association of functionally significant melanocortin-4 but not melanocortin-3 receptor mutations with severe adult obesity in a large North-American case control study. Hum Mol Genet 2009; 18: 1140-1147.
7. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-1095. (Pubitemid 36337319)
8. Lubrano-Berthelier C, Le Stunff C, Bougneres P, Vaisse C. A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans. J Clin Endocrinol Metab 2004; 89: 2028-2032. (Pubitemid 38619828)
9. Dubern B, Bisbis S, Talbaoui H, Le Beyec J, Tounian P, Lacorte JM et al. Homozygous null mutation of the melanocortin-4 receptor and severe early-onset obesity. J Pediatr 2007; 150: 613-617, 7 e1.
10. Kobayashi H, Ogawa Y, Shintani M, Ebihara K, Shimodahira M, Iwakura T et al. A Novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. Diabetes 2002; 51: 243-246. (Pubitemid 34518005)
11. Lubrano-Berthelier C, Durand E, Dubern B, Shapiro A, Dazin P, Weill J et al. Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet 2003; 12: 145-153. (Pubitemid 36124450)
12. Lubrano-Berthelier C, Cavazos M, Le Stunff C, Haas K, Shapiro A, Zhang S et al. The human MC4R promoter: characterization and role in obesity. Diabetes 2003; 52: 2996-3000. (Pubitemid 37466871)
13. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000; 106: 253-262. (Pubitemid 30483129)
14. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, We i R et al. CDC growth charts: United States. Adv Data 2000; 8: 1-27.
15. Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg 2007; 17: 565-568. (Pubitemid 46945427)
16. Reinehr T, Hebebrand J, Friedel S, Toschke AM, Brumm H, Biebermann H et al. Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene. Obesity (Silver Spring) 2009; 17: 382-389.
17. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005; 142: 547-559.
18. Dolan K, Fielding G. A comparison of laparoscopic adjustable gastric banding in adolescents and adults. Surg Endosc 2004; 18: 45-47. (Pubitemid 38133841)
19. Angrisani L, Favretti F, Furbetta F, Paganelli M, Basso N, Doldi SB et al. Obese teenagers treated by Lap-Band system: the Italian experience. Surgery 2005; 138: 877-881. (Pubitemid 41608482)
20. Hellstrom PM, Geliebter A, Naslund E, Schmidt PT, Yahav EK, Hashim SA et al. Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects. Br J Nutr 2004; 92 (Suppl 1): S47-S57. (Pubitemid 39214262)
21. Ellacott KL, Halatchev IG, Cone RD. Interactions between gut peptides and the central melanocortin system in the regulation of energy homeostasis. Peptides 2006; 27: 340-349. (Pubitemid 43162905)
22. Pournaras DJ, le Roux CW. Obesity, gut hormones, and bariatric surgery. World J Surg 2009; 33: 1983-1988.
23. Rottembourg D, O'Gorman CS, Urbach S, Garneau PY, Langer JC, Van Vliet G et al. Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma. J Pediatr Endocrinol Metab 2009; 22: 867-872.
24. Inge TH, Pfluger P, Zeller M, Rose SR, Burget L, Sundararajan S et al. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. Nat Clin Pract Endocrinol Metab 2007; 3: 606-609. (Pubitemid 47094564)
25. Muller HL, Gebhardt U, Wessel V, Schroder S, Kolb R, Sorensen N et al. First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klin Padiatr 2007; 219: 323-325. (Pubitemid 350239733)